GGrantIndex
← Leaderboards

Steven Holland

National Institute Of Allergy And Infectious Diseases

$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

By mechanism

Top collaborators

No co-investigators on record.

Most similar at National Institute Of Allergy And Infectious Diseases

Same institution · by research overlap

Others in their field

Top investigators on “Infection

Research focus

InfectionCytokineInterferon Type IiSyndromeDefectProductionReportingLungInterestGenesCohortGeneticIn VitroImmuneTuberculosisPredispositionMycobacterium InfectionsAffectEnrollmentPhagocytesAutoantibodiesOrganismHistoplasmosisMalignant Neoplasms

Grant awards (87)

Centralized Sequencing Program$3,478,640
ZIC · FY2025 · AI · contact PI
Tuberculosis Imaging Program$3,238,062
ZIC · FY2025 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$336,770
ZIA · FY2025 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$336,770
ZIA · FY2025 · AI · contact PI
Role of reactive oxygen species and the microbiome in intestinal barrier homeostasis$91,847
ZIA · FY2025 · AI · contact PI
Rituximab for Anticytokine Autoantibody-Associated Syndromes$91,847
ZIA · FY2025 · AI · contact PI
International Research in Thailand$91,847
ZIA · FY2025 · AI · contact PI
Tuberculosis Imaging Program$3,147,878
ZIC · FY2024 · AI · contact PI
Centralized Sequencing Program$2,839,363
ZIC · FY2024 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$658,891
ZIA · FY2024 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$450,646
ZIA · FY2024 · AI · contact PI
Rituximab for Anticytokine Autoantibody-Associated Syndromes$150,216
ZIA · FY2024 · AI · contact PI
International Research in Thailand$150,216
ZIA · FY2024 · AI · contact PI
Role of reactive oxygen species and the microbiome in intestinal barrier homeostasis$120,173
ZIA · FY2024 · AI · contact PI
Anticytokine Autoantibodies in COVID-19$19,619
ZIA · FY2024 · AI · contact PI
Centralized Sequencing Program$5,354,569
ZIC · FY2023 · AI · contact PI
Tuberculosis Imaging Program$2,783,766
ZIC · FY2023 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$1,086,518
ZIA · FY2023 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$1,086,518
ZIA · FY2023 · AI · contact PI
Rituximab for Anticytokine Autoantibody-Associated Syndromes$285,927
ZIA · FY2023 · AI · contact PI
International Research in Thailand$285,927
ZIA · FY2023 · AI · contact PI
Role of reactive oxygen species and the microbiome in intestinal barrier homeostasis$114,371
ZIA · FY2023 · AI · contact PI
Anticytokine Autoantibodies in COVID-19$23,911
ZIA · FY2023 · AI · contact PI
Centralized Sequencing Program$4,239,454
ZIC · FY2022 · AI · contact PI
Tuberculosis Imaging Program$2,596,620
ZIC · FY2022 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$1,104,328
ZIA · FY2022 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$1,104,328
ZIA · FY2022 · AI · contact PI
International Research in Thailand$276,083
ZIA · FY2022 · AI · contact PI
Rituximab for Anticytokine Autoantibody-Associated Syndromes$276,083
ZIA · FY2022 · AI · contact PI
Immune response to COVID-19 vaccination in individuals with immune disorders$248,499
ZIA · FY2022 · AI · contact PI
Role of reactive oxygen species and the microbiome in intestinal barrier homeostasis$105,742
ZIA · FY2022 · AI · contact PI
Anticytokine Autoantibodies in COVID-19$4,301
ZIA · FY2022 · AI · contact PI
Central Sequencing Initiative$3,888,314
ZIC · FY2021 · AI · contact PI
Tuberculosis Imaging Program$2,687,710
ZIC · FY2021 · AI · contact PI
International Research in Thailand$925,647
ZIA · FY2021 · AI · contact PI
Rituximab for Anticytokine Autoantibody-Associated Syndromes$925,647
ZIA · FY2021 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$435,600
ZIA · FY2021 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$435,599
ZIA · FY2021 · AI · contact PI
Anticytokine Autoantibodies in COVID-19$48,284
ZIA · FY2021 · AI · contact PI
Immune response to COVID-19 vaccination in individuals with immune disorders$48,284
ZIA · FY2021 · AI · contact PI
Central Sequencing Initiative$2,768,476
ZIC · FY2020 · AI · contact PI
Tuberculosis Imaging Program$2,320,134
ZIC · FY2020 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$1,580,416
ZIA · FY2020 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$1,580,414
ZIA · FY2020 · AI · contact PI
Rituximab for Anticytokine Autoantibody-Associated Syndromes$215,511
ZIA · FY2020 · AI · contact PI
International Research in Thailand$215,511
ZIA · FY2020 · AI · contact PI
Anticytokine Autoantibodies in COVID-19$44,205
ZIA · FY2020 · AI · contact PI
Tuberculosis Imaging Program$1,966,416
ZIC · FY2019 · AI · contact PI
Central Sequencing Initiative$1,443,862
ZIC · FY2019 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$1,140,822
ZIA · FY2019 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$1,140,820
ZIA · FY2019 · AI · contact PI
Rituximab for Anticytokine Autoantibody-Associated Syndromes$190,138
ZIA · FY2019 · AI · contact PI
International Research in Thailand$190,138
ZIA · FY2019 · AI · contact PI
Tuberculosis Imaging Program$3,984,712
ZIC · FY2018 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$1,168,549
ZIA · FY2018 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$1,168,549
ZIA · FY2018 · AI · contact PI
International Research in Thailand$233,710
ZIA · FY2018 · AI · contact PI
Rituximab for Anticytokine Autoantibody-Associated Syndromes$233,710
ZIA · FY2018 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$1,009,629
ZIA · FY2017 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$1,009,629
ZIA · FY2017 · AI · contact PI
International Research in Thailand$201,926
ZIA · FY2017 · AI · contact PI
Rituximab for Anticytokine Autoantibody-Associated Syndromes$201,926
ZIA · FY2017 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$1,047,553
ZIA · FY2016 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$1,047,553
ZIA · FY2016 · AI · contact PI
International Research in Thailand$174,592
ZIA · FY2016 · AI · contact PI
Rituximab for Anticytokine Autoantibody-Associated Syndromes$174,592
ZIA · FY2016 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$1,689,851
ZIA · FY2015 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$1,689,851
ZIA · FY2015 · AI · contact PI
International Research in Thailand$187,761
ZIA · FY2015 · AI · contact PI
Rituximab for Anticytokine Autoantibody-Associated Syndromes$83,246
ZIA · FY2015 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$1,650,367
ZIA · FY2014 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$1,611,986
ZIA · FY2014 · AI · contact PI
International Research in Thailand$575,709
ZIA · FY2014 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$2,042,766
ZIA · FY2013 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$2,042,766
ZIA · FY2013 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$1,799,653
ZIA · FY2012 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$1,711,994
ZIA · FY2012 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$1,680,287
ZIA · FY2011 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$1,608,506
ZIA · FY2011 · AI · contact PI
International Research in Thailand$43,547
ZIA · FY2011 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$2,016,453
ZIA · FY2010 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$1,818,591
ZIA · FY2010 · AI · contact PI
International Research in Thailand$55,001
ZIA · FY2010 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$2,440,402
ZIA · FY2009 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$2,057,099
ZIA · FY2009 · AI · contact PI
International Research in Thailand$126,863
ZIA · FY2009 · AI · contact PI
International Research in Thailand$55,178
Z01 · FY2008 · AI · contact PI